F
Frederick Petty
Researcher at Creighton University
Publications - 138
Citations - 8358
Frederick Petty is an academic researcher from Creighton University. The author has contributed to research in topics: Learned helplessness & Mania. The author has an hindex of 47, co-authored 138 publications receiving 8073 citations. Previous affiliations of Frederick Petty include University of Nebraska Medical Center & University of Texas Southwestern Medical Center.
Papers
More filters
Journal ArticleDOI
Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania
Charles L. Bowden,Andrew M. Brugger,Alan C. Swann,Joseph R. Calabrese,Philip G. Janicak,Frederick Petty,Steven C. Dilsaver,John M. Davis,A. John Rush,Joyce G. Small,Enrique S. Garza-Treviño,S.Craig Risch,Paul J. Goodnick,David D. Morris,V.S. Shu,Philip C. Johnson,M. Blake,Martin A Javors,Larry Ereshefsky,Terry McLeod,Arif M. Shoaib,Mark H. Johnson,Susan E. Kimmel,A. Wesley,R. Qualtiere,C. Trivedi,J. I. Javaid,Jeremy C. Peterson,Michael T. Lambert,Martin D. Zielinski,Paul J. Orsulak,L. Sharp,L. Akers,Marvin J. Miller,Jeffrey J. Kellams,G. Woodham,Alan Frazer +36 more
TL;DR: Divalproex was as effective in rapid-cycling manic patients as in other patients and appears to be independent of prior responsiveness to lithium, while lithium was significantly more effective than placebo in reducing the symptoms of acute mania.
Journal ArticleDOI
A Randomized, Placebo-Controlled 12-Month Trial of Divalproex and Lithium in Treatment of Outpatients With Bipolar I Disorder
Charles L. Bowden,Joseph R. Calabrese,Susan L. McElroy,Laszlo Gyulai,Adel A. Wassef,Frederick Petty,Harrison G. Pope,James C.-Y. Chou,Paul E. Keck,Linda J. Rhodes,Alan C. Swann,Robert M. A. Hirschfeld,Patricia Wozniak +12 more
TL;DR: Divalproex was superior to lithium in longer duration of successful prophylaxis in the study and less deterioration in depressive symptoms and Global Assessment Scale scores, and patients treated with divalproEx had better outcomes than those treated with placebo or lithium on several secondary outcome measures.
Journal ArticleDOI
Olanzapine Versus Placebo in the Treatment of Acute Mania
Mauricio Tohen,Todd M. Sanger,Susan L. McElroy,G.D. Tollefson,K. N. R. Chengappa,D. G. Daniel,Frederick Petty,Franca Centorrino,R. Wang,S. L. Grundy,M. Greaney,T. Jacobs,S.R. David,V. Toma +13 more
TL;DR: The olanzapine group experienced significantly greater mean mean scores than the placebo group in the treatment of acute mania, and the primary efficacy measure was defined as a change from baseline to endpoint in total score on the Young Mania Rating Scale.
Journal ArticleDOI
Depression During Mania: Treatment Response to Lithium or Divalproex
Alan C. Swann,Charles L. Bowden,David D. Morris,Joseph R. Calabrese,Frederick Petty,Joyce G. Small,Steven C. Dilsaver,John M. Davis +7 more
TL;DR: Investigation of the relation between depressive symptoms and treatment response in acute manic episodes suggests that even a modest level of pretreatment depression-related symptoms is a robust predictor of lithium nonresponse, and is associated with better response to divalproex.
Journal ArticleDOI
GABA and mood disorders: a brief review and hypothesis.
TL;DR: Low GABA function is proposed to be an inherited biological marker of vulnerability for development of mood disorders, applicable to a subset of mood disordered persons.